# A Pilot Study to Evaluate the Lipid Effects of TRIA-662

> **NCT02008084** · PHASE2 · COMPLETED · sponsor: **Cortria Corporation** · enrollment: 71 (actual)

## Conditions studied

- Hypertriglyceridemia
- Mixed Hyperlipidemia

## Interventions

- **DRUG:** TRIA-662
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02008084
- **Lead sponsor:** Cortria Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2016-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008084, "A Pilot Study to Evaluate the Lipid Effects of TRIA-662". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02008084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*